← Back to Search

Partner-based Exercise for Cancer Caregivers and Patients (C4C Trial)

N/A

Recruiting

Led By Melanie Keats, PhD

Research Sponsored by Nova Scotia Health Authority

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18+ years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, about 2 years

Awards & highlights

C4C Trial Summary

This trialwill study if an exercise program can help reduce stress and improve health of cancer caregivers and their care recipients.

Who is the study for?

This trial is for adult cancer patients at any stage of treatment, including up to 5 years post-treatment, and their caregivers. Caregivers must be providing support but not currently meeting the Canadian guidelines for physical activity (less than 150 minutes of moderate exercise per week). Both parties need to be able to do some low-intensity exercise and consent in English.Check my eligibility

What is being tested?

The study tests a 12-week partner-based exercise program's feasibility and acceptability. It aims to see if exercising together affects the caregiver's burden as well as both the caregiver’s and patient’s physical and psychological health.See study design

What are the potential side effects?

Since this is an exercise intervention, potential side effects may include typical risks associated with physical activity such as muscle soreness, fatigue or strain injuries. However, these are generally mild and can often be managed with proper guidance.

C4C Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

C4C Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, about 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, about 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, about 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adverse Events

Attrition

Intervention Adherence

+2 more

Secondary outcome measures

Aerobic Fitness

Balance

Body Composition

+12 more

C4C Trial Design

1Treatment groups

Experimental Treatment

Group I: Multimodal Exercise InterventionExperimental Treatment1 Intervention

12-week, twice weekly partner-based multimodal exercise program

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Multimodal exercise

2021

N/A

~70

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor

258 Previous Clinical Trials

83,794 Total Patients Enrolled

Melanie Keats, PhDPrincipal InvestigatorDalhousie University / Nova Scotia Health

1 Previous Clinical Trials

1,500 Total Patients Enrolled

Media Library

Multimodal exercise Clinical Trial Eligibility Overview. Trial Name: NCT05333016 — N/A

Cancer Research Study Groups: Multimodal Exercise Intervention

Cancer Clinical Trial 2023: Multimodal exercise Highlights & Side Effects. Trial Name: NCT05333016 — N/A

Multimodal exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05333016 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial still recruiting participants?

"According to the latest update uploaded on clinicaltrials.gov, this medical trial is searching for participants and was initially opened for recruitment on January 15th 2023. It has since been amended with a fresh upload dated February 6th 2023."

Answered by AI

How many participants are expected to join this medical study?

"Affirmative. According to clinicaltrials.gov, this medical research is in the process of recruiting applicants. It was initially posted on January 15th 2023 and most recently modified February 6th 2023. The study requires 60 volunteers from a singular site."

Answered by AI

What is the aim of this investigation?

"The primary objective assessed over a 12-week period post-intervention is patient adherence. Secondary outcomes include quality of life for cancer patients (as evaluated by the Functional Assessment of Cancer Therapy - General survey), resting blood pressure, and body mass index."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Dyadic Approach to Cancer Care: A Feasibility and Efficacy Partner-based Exercise Study

Melanie Keats 2023. "A Dyadic Approach to Cancer Care: A Feasibility and Efficacy Partner-based Exercise Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05333016.